Target intelligence / Profile preview

Insulin receptor-related receptor (INSRR)

Target
INSRR
Molecular classification
Receptor, Tyrosine kinase receptor, Transmembrane receptor protein tyrosine kinase
01

Overview

Insulin receptor-related receptor is a transmembrane receptor tyrosine kinase that shares homology with both the insulin receptor and the IGF-1 receptor. Its canonical function is as a pH sensor: it is activated by increased extracellular pH, which leads to intracellular signaling mediated by phosphorylation of IRS1 and activation of AKT pathways[2][6]. Although part of a well-known receptor family, INSRR is considered an orphan receptor with no identified endogenous peptide ligand, and its definitive physiological roles are less understood than those of insulin or IGF receptors. It is implicated in developmental processes of neural tissue and possibly in male sexual differentiation[1]. Its expression has been detected predominantly in subsets of neuronal cells and tumor cell lines[1]. INSRR has not been established as a direct drug target, nor have selective drugs or biomarkers for this protein entered clinical use. Disease relevance may exist via pathway crosstalk in diabetes and cancer, but direct causal roles are not yet well resolved[1][2][5][6].

Other names
Insulin receptor-related proteinIRRIR-related receptorinsulin receptor-related protein alpha chaininsulin receptor-related protein beta chain
02

Mechanism of action

Not established for drugs. For endogenous function, activation occurs through increased extracellular pH, possibly leading to IRS1 and AKT intracellular signal transduction

03

Biological functions

Signal transductionProtein autophosphorylationCellular response to alkaline pH (functions as a pH sensing receptor)Actin cytoskeleton organization
04

Disease associations

Type 2 diabetes mellitus (possible association through receptor family)Rickettsialpox (associated diseases in genetic studies, but causality or mechanistic role unclear)Regular astigmatism (association noted in genetic studies)
05

Safety considerations

None specifically reported for INSRR-modulating drugs. As a family member of insulin/IGF receptors, theoretical concerns include metabolic disturbance, cancer risk, and cell proliferation effects if targeted

Beyond the preview

Go deeper on Insulin receptor-related receptor (INSRR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insulin receptor-related receptor (INSRR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call